Antimicrobial Resistance in Campylobacter Species: Mechanisms and Genomic Epidemiology.

Abstract

The Campylobacter genus is a large and diverse group of Gram-negative bacteria that are known to colonize humans and other mammals, birds, reptiles, and shellfish. While it is now recognized that several emerging Campylobacter species can be associated with human disease, two species, C. jejuni and C. coli, are responsible for the vast majority of bacterial gastroenteritis in humans worldwide. Infection with C. jejuni, in particular, has also been associated with a number of extragastrointestinal manifestations and autoimmune conditions, most notably Guillain-Barré syndrome. The antimicrobial drugs of choice for the treatment of severe Campylobacter infection include macrolides, such as erythromycin, clarithromycin, or azithromycin. Fluoroquinolones, such as ciprofloxacin, are also commonly used for empirical treatment of undiagnosed diarrheal disease. However, resistance to these and other classes of antimicrobial drugs is increasing and is a major public health problem. The US Centers for Disease Control and Prevention estimates that over 300,000 infections per year are caused by drug-resistant Campylobacter. In this chapter, we discuss the taxonomy of the Campylobacter genus, the clinical and global epidemiological aspects of Campylobacter infection, with an emphasis on C. jejuni and C. coli, and issues related to the treatment of infection and antimicrobial resistance mechanisms. We further discuss the use of next-generation sequencing for the detection and surveillance of antimicrobial resistance genes.

• Authors: Chris A Whitehouse, Shaohua Zhao, Heather Tate
• Journal: Advances in applied microbiology (Adv Appl Microbiol) Vol. 103 Pg. 1-47 ( 2018) ISSN: 0065-2164 [Print] United States
• PMID: 29914655 (Publication Type: Journal Article)
• Copyright: © 2018 Elsevier Inc. All rights reserved.

Chemical References

• Anti-Bacterial Agents

Topics

• Animals
• Anti-Bacterial Agents (pharmacology, therapeutic use)
• Campylobacter (classification, drug effects, genetics, isolation & purification)
• Campylobacter Infections (drug therapy, epidemiology, microbiology, veterinary)
• Drug Resistance, Bacterial
• Genes, Bacterial
• Genotyping Techniques (methods)
• Global Health
• High-Throughput Nucleotide Sequencing (methods)
• Humans
• Microbial Sensitivity Tests (methods)